Is Helicobacter pylori the Infectious Trigger for Headache?: A Review

Author(s): Lidia Savi, Davide G. Ribaldone, Sharmila Fagoonee, Rinaldo Pellicano

Journal Name: Infectious Disorders - Drug Targets
Formerly Current Drug Targets - Infectious Disorders

Volume 13 , Issue 5 , 2013

Become EABM
Become Reviewer
Call for Editor


The interest that surrounds the bacterium Helicobacter pylori (H. pylori) is due not only to its causal role in several gastroduodenal diseases, but also to its supposed involvement in the pathogenesis of extra-gastric manifestations. This review provides a literature update on the hypothetic correlation between H. pylori and headache. To identify all publications on this issue, a MEDLINE search of all studies published in English from 1965 to 2013 was conducted. The authors examined three aspects of this potential association: epidemiology, intervention trials and pathogenesis. While in the former, the results are contradictory, in the intervention studies, it has been documented that at 6 and 12 months, bacterial eradication is associated to disappearance of symptoms in 23% and 28% of cases, and to a significant decrease of intensity, frequency and duration of acute attacks in the remaining patients. Under a pathogenetic aspect, if H. pylori has a role, it does not act through oxidative stress. In conclusion, the eradication of H. pylori seems efficient at least in a subgroup of patients suffering from migraine. Further investigations should focalize on particular subgroups of patients and, encouraged from data produced by intervention studies, evaluate the long-term benefit of eradication.

Keywords: Antimicrobials, antisecretive drugs, headache, Helicobacter pylori, migraine.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2013
Published on: 01 December, 2013
Page: [313 - 317]
Pages: 5
DOI: 10.2174/1871526513666131201125021
Price: $65

Article Metrics

PDF: 28